Featured Research

from universities, journals, and other organizations

Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says

Date:
October 7, 2006
Source:
BMJ-British Medical Journal
Summary:
Physiotherapy or a "wait and see" approach are both more effective in tackling tennis elbow than corticosteroid injections, a British Medical Journal study reveals. Researchers in Australia tested different treatments on three separate groups of patients with tennis elbow. One group of participants were allocated the "wait and see" approach -- they were reassured that the condition would eventually settle down and encouraged to wait. They were also given specific instructions on modifying their daily activities so to avoid aggravating their pain.

Physiotherapy or a 'wait and see' approach are both more effective in tackling tennis elbow than corticosteroid (steroid) injections, a British Medical Journal study reveals.

Researchers in Australia tested different treatments on three separate groups of patients with tennis elbow. One group of participants were allocated the 'wait and see' approach -- they were reassured that the condition would eventually settle down and encouraged to wait. They were also given specific instructions on modifying their daily activities so to avoid aggravating their pain.

A second group were given a local corticosteroid injection and advised to gradually return to normal activities. The final group received eight treatments of physiotherapy of 30 minutes over six weeks and were taught home exercises and self-manipulation. The physiotherapy group also received a resistant exercise band and exercise instruction booklet. Each group's progress was measured at six weeks, and again after a year.

Initially, corticosteroid injections were the most successful treatment, with 78% of those in the group reporting improvements, followed closely by physiotherapy with a 65% success rate when compared to just 27% in the 'wait and see' group.

However, after 52 weeks the injection group rates of improvement were significantly worse than those of the physiotherapy group. The injection group also had the most reported recurrences, with 72% of participants' condition deteriorating after three or six weeks -- which could be due, in part, to a quicker initial recovery leading to greater use and over-taxing of the elbow.

The research also found that the superior long-term effects of physiotherapy were replicated by the wait and see approach -- at the end of the study participants in both the physiotherapy and wait and see group had either much improved or completely recovered.

The authors say that "the...poor overall performance of corticosteroid injections should be taken under consideration by both the patient and their doctor in management of tennis elbow."

The study findings also support the idea that tennis elbow is, in most cases, a self-limiting condition. They conclude that "patients with tennis elbow can be reassured that, in the majority of cases, they will improve in the long-term when given information and ergonomic advice about their condition."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says." ScienceDaily. ScienceDaily, 7 October 2006. <www.sciencedaily.com/releases/2006/09/060929093850.htm>.
BMJ-British Medical Journal. (2006, October 7). Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/09/060929093850.htm
BMJ-British Medical Journal. "Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow, Study Says." ScienceDaily. www.sciencedaily.com/releases/2006/09/060929093850.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins